Scientists from the University of Otago in New Zealand have figured out how recently the Seneca Valley virus (also known as the Seneca Valley virus, or SVV) has been detected and interacts with cancer cells.
As noted apothekegenerika.de, specialists using high-resolution cryoelectron microscopy (samples are examined at low temperatures) analyze how the virus acts on the receptors of cancer cells.
Therefore, it turned out that the Seneca Valley virus interacts with the protein receptor ANTXR1 located on the surface of cancer cells. At the same time, the ANTXR2 gene, which is characteristic only for healthy tissues, does not affect the infection. According to scientists, in the future it will help develop a new way to combat malignant tumors.
True, clinical trials have shown that Seneca Valley is effective in fighting cancer, but for two weeks the body produces immunity to it.
So, scientists will try to develop a method of applying the Seneca-Valli virus, in which the body does not develop resistance to it. And for this it is necessary to modify the virus in such a way as to leave unchanged only the part that interacts with the cancer cells.
